Xcout Intel
Ratio Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Ratio Therapeutics among biotech companies — ranked by similarity to what Ratio Therapeutics actually does, not by market-cap band.
Subscribe to see Ratio Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Ratio Therapeutics
Ratio Therapeutics is a clinical-stage pharmaceutical company headquartered in Boston, Massachusetts. The company employs a suite of innovative technologies for the discovery and early clinical development of targeted radiopharmaceuticals.
Ratio Therapeutics at a glance
Ratio Therapeutics is a biotech company headquartered in United States. It has raised at least $140.7M across the 3 funding rounds on record. Its most recent funding round, Series C, raised $70M in July 2026. Xcout tracks 18 named people at Ratio Therapeutics, including Jack Hoppin, Ph.D. (Chairman, Chief Executive Officer).
Ratio Therapeutics leadership
- Jack Hoppin, Ph.D.Chairman, Chief Executive Officer
- Colin Hayward, M.B. B.S.Chief Medical Officer
- Jacob Hesterman, Ph.D .Chief Data Officer
- Marc Becker, M.B.A, CPAChief Financial and Operating Officer
- Marcel Reichen, Ph.D, M.B.AChief Strategy Officer
- Matthias Friebe, Ph.D.Chief Development Officer
12 more named people on record for Ratio Therapeutics, with roles, board committees and tenure — see the full roster →
Ratio Therapeutics funding rounds
At least $140.7M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $70M | 5 named | |
| Series C | $50.7M | 5 named | |
| Series C | $20M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Ratio Therapeutics news
Top 12 Ratio Therapeutics competitors
Ranked by semantic similarity — how close each company is to Ratio Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
Rapport Therapeutics, Inc. functions as a clinical-phase biopharmaceutical enterprise, concentrating its efforts on discovering and developing innovative small-molecule therapeutics for individuals living with central nervous system (CNS) disorders. Its flagship product candidate, RAP-219, is an experimental small molecule precisely designed to inhibit TARPy8-containing AMPARs with exceptional potency (picomolar affinity). This promising compound aims to treat focal epilepsy and a range of other neurological conditions, including peripheral neuropathic pain and bipolar disorder. The company's pipeline further includes RAP-199, another molecule targeting TARPy8, which boasts distinct chemical and pharmacokinetic profiles. Moreover, Rapport is advancing several nicotinic acetylcholine receptor (nAChR) programs, such as an a6 nAChR therapy for chronic pain and an a9a10 nAChR treatment intended for hearing impairments. Formed in 2022 under the initial name Precision Neuroscience NewCo, Inc., the company adopted its current identity as Rapport Therapeutics, Inc. in October 2022, and its operations are based in Boston, Massachusetts.
Biotechnology
BIND Therapeutics, Inc. is a clinical-stage nanomedicine company headquartered in Cambridge, Massachusetts. The company specializes in developing targeted and programmable therapeutics using its proprietary platform to treat various diseases.
Biotechnology
Alloy Therapeutics, Inc. is a biotechnology ecosystem company dedicated to democratizing access to antibodies, multispecifics, and genetic modalities, with offices in Waltham and Boston, Massachusetts.
Similar biotech company
Remix Therapeutics, Inc. is a biotechnology company headquartered in Watertown, Massachusetts. The company specializes in developing novel therapies that alter RNA processing to address serious diseases.
Biotechnology
76Bio, Inc. is a biotechnology company founded in 2020 and based in Boston, United States. The company develops therapeutics for patients with life-threatening diseases by pioneering targeted protein degraders.
Biotechnology
DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools, and automation to discover novel small molecules.
Similar biotech company
Photys Therapeutics, Inc. is a proximity-based biotechnology holding company founded in 2021 and headquartered in Massachusetts, United States. The company focuses on discovering and developing novel targeted protein therapeutics.
Biotechnology
Full-Life Technologies Limited is a fully integrated global radiopharmaceutical company focused on drug development in oncology, headquartered in Shanghai, China, with additional operations in Europe.
Similar biotech company
Relation Therapeutics Inc. is an active for-profit biotechnology company founded in 2019 that focuses on therapeutic development.
Similar biotech company
Metaphore Biotechnologies, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, operating as part of Flagship Pioneering. The company focuses on therapeutic design, leveraging AI and machine learning technologies for drug discovery and development.
Similar biotech company
Foghorn Therapeutics is a biopharmaceutical company headquartered in Watertown, Massachusetts. The company is pioneering a new class of medicines that treat serious diseases by leveraging insights into the chromatin regulatory system.
Biotechnology
Exo Therapeutics is a small molecule drug discovery and development biotechnology company headquartered in Cambridge, Massachusetts. The company utilizes a pioneering proprietary technology platform to unlock and address notoriously intractable pharmaceutical and disease targets.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Ratio Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Ratio Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →